Cystinotic patients have been shown to excrete in their urine high levels of pyroglutamate, an intermediate metabolite of the adenosine triphosphate (ATP)-dependent ␥-glutamyl cycle, which is responsible for glutathione (GSH) synthesis. Human fibroblasts were used to study the mechanisms leading to pyroglutamate accumulation in nephropathic cystinosis (NC). We show that inhibition of ATP synthesis caused a marked intracellular accumulation of pyroglutamate, reflecting decreased GSH synthesis. Despite similar degrees of ATP depletion, pyroglutamate increased more in cystinotic fibroblasts than in controls, while GSH decreased to lower levels. In addition, cystinotic cells exposed to oxidative stress (hydrogen peroxide) were unable to increase their GSH concentration above baseline. These results could not be attributed to differences in mitochondrial oxidative activity or to increased apoptotic cell death. Together, these results support the hypothesis that cysteine derived from lysosomal cystine efflux limits the activity of the ␥-glutamyl cycle and GSH synthesis. Lysosome cystine accumulation leads to cell damage, which causes various clinical symptoms including hypothyroidism, diabetes mellitus, failure to thrive, progressive neuropathy and myopathy, and severe early-onset renal Fanconi syndrome. To date, the pathophysiology of cell damage in NC remains poorly understood.In a previous study, we showed that patients with NC have elevated urinary pyroglutamic acid (PG) (5-oxoproline) excretion, which returns to near-normal levels after cysteamine treatment (4). PG and cytosolic cysteine represent two major metabolites of the ATP-dependent ␥-glutamyl cycle, which constitutes the primary metabolic pathway for the synthesis of the soluble antioxidant agent GSH (Fig. 1) (5).The aim of the present study was to further investigate the role of the ␥-glutamyl cycle in NC using human fibroblast cell cultures obtained from NC patients.
METHODSCell cultures. Human fibroblasts from four unrelated NC patients were kindly provided by the Cell Lines and DNA Bank of Patients Affected by Genetic Diseases (Laboratorio di Diagnosi Pre e Postnatale delle Malattie Metaboliche, Istituto G. Gaslini, Italy, partially supported by the Telethon Foundation). Control fibroblasts were isolated from skin biopsies obtained from four unrelated healthy subjects. Cells were grown at 37°C in humidified 5% CO 2 /95% air in Dulbecco modified Eagle medium supplemented with 10% fetal bovine serum, 100 U/mL penicillin, and 100 mg/mL streptomycin. Cell culture media and solutions were from GIBCO-Invitrogen (Paisley, UK).Measurement of intracellular ATP. Intracellular ATP levels were measured with the ATP Bioluminescence Assay Kit CLS II (Roche, Mannheim, Germany), according to the protocol provided by the vendor. Samples were analyzed on a Victor 2 1420 Multilabel Counter (Perkin Elmer, Boston, MA). ATP concentrations were calculated from a log-log plot of the standard curve. The data were expressed as nmol/mg of proteins.Measurement of intra...